AKEEGA 100 mg/500 mg, film-coated tablet 56 tablets
Active ingredients: Abiraterone, Abiraterone acetate, Niraparib, Niraparib tosylate monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AKEEGA 100 mg/500 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVDC polyéthylène PVC aluminium de 56 comprimé(s)
- Marketing authorisation holder
- JANSSEN CILAG INTERNATIONAL NV
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Aug 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69324990CIP73027124CIP133400930271247Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TOSYLATE DE NIRAPARIB MONOHYDRATÉcomprimé | — | SA |
| ACÉTATE D'ABIRATÉRONEcomprimé | 500 mg · un comprimé | SA |
| ABIRATÉRONEcomprimé | 446 mg · un comprimé | FT |
| NIRAPARIBcomprimé | 100 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.